What does life sciences — acquisitions, earn outs and other mean?

Costs related to integrating and paying out earn-outs for businesses acquired by the Life Sciences segment.

How do you interpret life sciences — acquisitions, earn outs and other?

Higher costs indicate active integration of new acquisitions, which may temporarily depress segment margins.

How does life sciences — acquisitions, earn outs and other compare across companies?

Similar to acquisition-related expense line items found in the SG&A or operating expense sections of peer companies.

Revvity RVTY Life Sciences — Acquisitions, earn outs and other

Similar metrics at other companies

TMOLife Sciences Solutions — Restructuring and other costs

$9M—

PEA

PEAKLife Science — Transaction costs

——

PEA

PEAKLifescience — Business Combination Acquisition Related Costs

——

PEA

PEAKLifescience — Payments To Acquire Businesses Net Of Cash Acquired

——

PEA

PEAKLab Buildings — Transaction and merger-related costs

——

PEA

PEAKLifescience — Payments To Acquire Real Estate

——

Other financials

Income statement

See full

Revenue$711.1M+7.0%

Gross profit$387.7M+3.2%

Operating income$75.9M+5.1%

Net income$40.7M-3.6%

EPS (diluted)$0.36+2.9%

Balance sheet

See full

Cash & equivalents$861.5M-24.3%

Total debt$3.9B+17.8%

Total equity$7.2B-5.9%

Total assets$12.0B-2.9%

Cash flow

See full

Operating cash flow$115.2M-10.1%

CapEx$19.8M+23.7%

Free cash flow$95.5M-14.9%

Valuation

See full

Market cap$11.16B-22.9%

Enterprise value$14.24B-13.7%

P/E46.5×-4.0×

P/S3.8×-1.4×

Profitability

See full

Gross margin48.5%—

Operating margin12.4%-1.1pp

Net margin8.3%-2.1pp

FCF margin17%-1.9pp

Returns & leverage

See full

Return on equity3.2%-0.5pp

Debt / equity0.5×+0.1×

Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept revv:GoodwillAcquisitionEarnOutsAndOtherAdjustments.

The official record: Revvity’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revvity's life sciences — acquisitions, earn outs and other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Revvity's life sciences — acquisitions, earn outs and other?: Revvity (RVTY) reported life sciences — acquisitions, earn outs and other of $24.5M in Q4 2025.
What does life sciences — acquisitions, earn outs and other mean?: Costs related to integrating and paying out earn-outs for businesses acquired by the Life Sciences segment.
How do you interpret life sciences — acquisitions, earn outs and other?: Higher costs indicate active integration of new acquisitions, which may temporarily depress segment margins.
How does life sciences — acquisitions, earn outs and other compare across companies?: Similar to acquisition-related expense line items found in the SG&A or operating expense sections of peer companies.